According to the analysis by quantitative reverse-transcription polymerase chain reaction, the AKR1B1 mRNA level significantly decreased by 50% in human glioma tissues (Figure 1A), suggesting that low AKR1B1 levels participated in tumorigenesis. This evidence concerns the gene AKR1B1 and central nervous system cancer.